3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Colorectal Neoplasms
1
Interventions
Sorafenib
3
atezolizumab
2
Radiotherapy
2
Bevacizumab
2
tremelimumab
1
temsirolimus
1
lonafarnib
1
liposomal doxorubicin
1
infigratinib
1
gadolinium ethoxybenzyl DTPA
1
fludarabine
1
durvalumab
1
cabozantinib
1
bavituximab
1
aldesleukin
1
Thoracoscopy
1
Thoracic Surgery, Video-Assisted
1
Resveratrol
1
Radiosurgery
1
Radionuclide Generators
1
Radiofrequency Ablation
1
Polymerase Chain Reaction
1
Oxaliplatin
1
Nivolumab
1
NSC 366140
1
Mass Spectrometry
1
Immunotherapy
1
Immunohistochemistry
1
Genetic Testing
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Liver Neoplasms
×
Radionuclide Generators
×
Clear all
NCT00510627
2017-03-03
Prometheus
Boston Scientific Corporation
Phase 4
Withdrawn